摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

dimethyldiethylammonium cation | 15302-89-3

中文名称
——
中文别名
——
英文名称
dimethyldiethylammonium cation
英文别名
dimethyl-diethylammonium ion;diethyldimethylammonium;diethyl-dimethyl-ammonium;Dimethyl-diaethyl-ammoniumhydroxyd;Diaethyl-dimethyl-ammonium;Diethyldimethylammoniumion;Ethanaminium, N-ethyl-N,N-dimethyl-;diethyl(dimethyl)azanium
dimethyldiethylammonium cation化学式
CAS
15302-89-3
化学式
C6H16N
mdl
——
分子量
102.2
InChiKey
ZJHQDSMOYNLVLX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    7
  • 可旋转键数:
    2
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

SDS

SDS:6a4df2c69c244889fbedfa7c641e99e7
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Compounds for non-invasive measurement of aggregates of amyloid peptides
    申请人:Technische Universität München
    公开号:EP2218464A1
    公开(公告)日:2010-08-18
    The invention relates to the provision of compounds, methods for producing them, and their use for imaging and quantification of aggregates of amyloid peptides in vivo. In a preferred aspect of the invention, a tracer is administered to humans and displays enrichment in the areas that are containing amyloid plaques. Tracers of the invention can be used for in vivo visualization and quantification of aggregates of amyloid peptides in patients affected diseases characterized in the generation of aggregates of amyloid peptides, for example familial or sporadic Alzheimer's disease and type II diabetes. Tracers of the invention can be used for monitoring effects of amyloid-modulating therapies of patients affected with diseases characterized in the generation of aggregates of amyloid peptides, for example familial or sporadic Alzheimer's disease and type II diabetes.
    该发明涉及化合物的提供、生产方法以及它们在体内成像和定量淀粉样肽聚集物的用途。在该发明的一个优选方面,向人类施用一种示踪剂,并且在含有淀粉样斑块的区域显示富集。该发明的示踪剂可用于患有以生成淀粉样肽聚集物为特征的疾病的患者体内成像和定量,例如家族性或散发性阿尔茨海默病和2型糖尿病。该发明的示踪剂可用于监测患有以生成淀粉样肽聚集物为特征的疾病的患者对调节淀粉样蛋白的疗法的影响,例如家族性或散发性阿尔茨海默病和2型糖尿病。
  • [EN] CYANOGUANIDINES AND THEIR USE AS ANTIVIRAL AGENTS<br/>[FR] CYANOGUANIDINES ET LEUR UTILISATION COMME AGENTS ANTIVIRAUX
    申请人:ABBVIE INC
    公开号:WO2014005129A1
    公开(公告)日:2014-01-03
    This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
    这份披露涉及:(a) 抑制RSV感染和/或复制的化合物及其盐,等等;(b) 用于制备这些化合物和盐的中间体;(c) 包含这些化合物和盐的组合物;(d) 制备这些中间体、化合物、盐和组合物的方法;(e) 使用这些化合物、盐和组合物的方法;以及(f) 包含这些化合物、盐和组合物的试剂盒。
  • ORGANIC ELECTRONIC MATERIAL, POLYMERIZATION INITIATOR AND THERMAL POLYMERIZATION INITIATOR, INK COMPOSITION, ORGANIC THIN FILM AND PRODUCTION METHOD FOR SAME, ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, LIGHTING DEVICE, DISPLAY ELEMENT, AND DISPLAY DEVICE
    申请人:Ishitsuka Kenichi
    公开号:US20130037753A1
    公开(公告)日:2013-02-14
    Disclosed is an organic electronic material comprising charge transporting compounds and ionic compounds having electron-accepting properties and high solubility in a solvent. The organic electronic material is characterized by comprising charge transporting compounds and ionic compounds, and in that at least one of the ionic compounds is any one kind of compounds represented by general formulas (1b)-(3b). (In the formulas Y 1 -Y 6 each independently represent a divalent linking group, R 1 -R 6 each independently represent an electron-attracting organic substituent (these structures can further have substituents and hetero-atoms, and R 1 , R 2 and R 3 , or, R 4 -R 6 can respectively combine and become a ring shape or a polymer shape) and L + represents a monovalent cation.)
    本文揭示了一种有机电子材料,包括具有电荷传输化合物和具有接受电子性质且在溶剂中具有高溶解度的离子化合物。该有机电子材料的特点在于包括电荷传输化合物和离子化合物,并且至少其中一个离子化合物是由通用式(1b)-(3b)表示的化合物中的任意一种。(在式中,Y1-Y6分别表示二价连接基团,R1-R6分别表示吸引电子的有机取代基(这些结构可以进一步具有取代基和杂原子,且R1、R2和R3,或者R4-R6可以分别结合形成环状或聚合物形状),L+表示一价阳离子。)
  • Novel perfluoroalkanesulfonamide compounds
    申请人:Umemoto Teruo
    公开号:US20070093678A1
    公开(公告)日:2007-04-26
    The present invention provides compounds represented by the formula Y +− N(SO 2 R f )(CF 3 ). Such a compound can be manufactured through a reaction between M +− N(SO 2 R f )(CF 3 ) and Y +− B. The present invention also provides compounds represented by the formula Y +− N(SO 2 R f )(CN). Such a compound can be manufactured through a reaction between M +− N(SO 2 R f )(CN) and Y +− B. R f in the above formulae is a perfluoroalkyl group. Y + is an organic or inorganic cation. − B is an organic or inorganic anion. M + is an alkali metal cation or a silver cation.
    本发明提供了以下公式表示的化合物Y+−N(SO2Rf)(CF3)。这样的化合物可以通过M+−N(SO2Rf)( )和Y+−B之间的反应制造。本发明还提供了以下公式表示的化合物Y+−N(SO2Rf)(CN)。这样的化合物可以通过M+−N(SO2Rf)(CN)和Y+−B之间的反应制造。上述公式中的Rf是全氟烷基。Y+是有机或无机阳离子。−B是有机或无机阴离子。M+是碱属阳离子或阳离子。
  • RADICAL POLYMERIZATION INITIATOR, COMPOSITION CONTAINING SAME, CURED PRODUCT OF COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT, AND COMPOUND
    申请人:ADEKA CORPORATION
    公开号:US20210107887A1
    公开(公告)日:2021-04-15
    Provided are: a radical polymerization initiator which has excellent sensitivity and solubility in water; a composition containing the same; a cured product of the composition; a method of producing the cured product; and a compound. The radical polymerization initiator contains a compound represented by Formula (A) below (wherein Z 1 represents a direct bond or the like; Z 2 represents >CR 102 2 or the like; R 1 to R 8 each represent a hydrogen atom or the like, or a group containing a salt-forming group, which is represented by Formula (B1) below (wherein L 1 represents a direct bond or the like, B represents an acidic group salt or the like, b represents 1 to 10, and the asterisk (*) represents a binding site); at least one of R 1 to R 8 is the group containing a salt-forming group; R 101 and the like each represent a hydrogen atom or the like; one or more hydrogen atoms in the alkyl group and the like used as R 1 to R 8 and the like are optionally substituted with an ethylenically unsaturated group or the like; one or more methylene groups in R 1 to R 8 and the like are optionally substituted with a double bond or the like; adjacent groups such as R 1 and R 2 are optionally bound together to form a ring and optionally form a fused ring with a benzene ring in Formula (A); and R′ represents a hydrogen atom or the like).
    提供了:具有优异灵敏度和溶性的自由基聚合引发剂;含有该引发剂的组合物;该组合物的固化产物;生产该固化产物的方法;以及一种化合物。自由基聚合引发剂包含以下式(A)所代表的化合物(其中Z1代表直接键或类似物;Z2代表>CR1022或类似物;R1至R8各自代表氢原子或类似物,或者包含盐形成基团的群,该基团由下式(B1)代表(其中L1代表直接键或类似物,B代表酸性基团盐或类似物,b代表1至10,星号(*)代表结合位);R1至R8中至少有一个是包含盐形成基团的群;R101等各自代表氢原子或类似物;R1至R8等中所用的烷基群等中的一个或多个氢原子可以选择性地被乙烯不饱和基团等替代;R1至R8等中的一个或多个亚甲基群可以选择性地被双键等替代;相邻的群,如R1和R2,可以选择性地结合在一起形成环,并且可以选择性地与式(A)中的苯环形成融合环;R′代表氢原子或类似物)。
查看更多

同类化合物

(乙腈)二氯镍(II) (R)-(-)-α-甲基组胺二氢溴化物 (N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-3-氨基环丁烷甲腈盐酸盐 顺式-2-羟基甲基-1-甲基-1-环己胺 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺二盐酸盐 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷